Exploratory analysis of angiotensin converting enzyme (ACE) and aldosterone (Ald) serum levels as prognostic and predictive biomarkers on the NCIC CTG BR24 trial.
Jair Bar
Consultant or Advisory Role - AstraZeneca
Keyue Ding
No relevant relationships to disclose
Huijun Zhao
No relevant relationships to disclose
Scott Andrew Laurie
Research Funding - AstraZeneca
Lei Han
No relevant relationships to disclose
Frances A. Shepherd
Consultant or Advisory Role - AstraZeneca; Biodesix; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck; Recombio; Roche
Stock Ownership - Lilly; Pfizer
Honoraria - GlaxoSmithKline; Lilly; Roche
Expert Testimony - AstraZeneca
Christina L. Addison
No relevant relationships to disclose
Glenwood D. Goss
Consultant or Advisory Role - AstraZeneca
Honoraria - AstraZeneca
Research Funding - AstraZeneca
Jim Dimitroulakos
No relevant relationships to disclose
Penelope Ann Bradbury
Research Funding - AstraZeneca